These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9039534)
1. In vivo and in vitro antifungal activity of the polyene derivative SPA-S-753 against encapsulated form of Cryptococcus neoformans. Strippoli V; D'Auria FD; Simonetti N; Basti D; Bruzzese T Infection; 1997; 25(1):27-31. PubMed ID: 9039534 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of a new partricin A derivative (N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diaspartate) in mice. Rimaroli C; Bonabello A; Sala P; Bruzzese T J Pharm Sci; 2002 May; 91(5):1252-8. PubMed ID: 11977101 [TBL] [Abstract][Full Text] [Related]
3. Overview of SPA-S-843 in vitro activity against filamentous fungi. Rimaroli C; Bruzzese T Chemotherapy; 2000; 46(1):28-35. PubMed ID: 10601795 [TBL] [Abstract][Full Text] [Related]
5. Antimycotic activity in vitro and in vivo of a new hydrosoluble polyene antibiotic. Strippoli V; Evangelista AM; Simonetti N Farmaco Sci; 1976 Dec; 31(12):891-900. PubMed ID: 1017483 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of SPK-843, a novel polyene antifungal, in a murine model of systemic cryptococcosis. Kakeya H; Miyazaki Y; Senda H; Kobayashi T; Seki M; Izumikawa K; Yamamoto Y; Yanagihara K; Tashiro T; Kohno S Antimicrob Agents Chemother; 2008 May; 52(5):1871-2. PubMed ID: 18299408 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of a new polyene, SPA-S-843, against yeasts. Rimaroli C; Bruzzese T Antimicrob Agents Chemother; 1998 Nov; 42(11):3012-3. PubMed ID: 9797244 [TBL] [Abstract][Full Text] [Related]
8. Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection. Zaragoza O; Mihu C; Casadevall A; Nosanchuk JD Antimicrob Agents Chemother; 2005 Oct; 49(10):4358-61. PubMed ID: 16189121 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine. Strippoli V; Torosantucci A; Simonetti N Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Schwarz P; Dromer F; Lortholary O; Dannaoui E Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis. Clemons KV; Stevens DA J Antimicrob Chemother; 2001 Feb; 47(2):183-6. PubMed ID: 11157903 [TBL] [Abstract][Full Text] [Related]
12. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Joseph-Horne T; Hollomon D; Loeffler RS; Kelly SL Antimicrob Agents Chemother; 1995 Jul; 39(7):1526-9. PubMed ID: 7492098 [TBL] [Abstract][Full Text] [Related]
13. Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis. Luna T; Mazzolla R; Romanò G; Blasi E Antimicrob Agents Chemother; 1997 Mar; 41(3):706-8. PubMed ID: 9056019 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a new derivative of partricin A (SPA-S-753) in rodents. Galmozzi MR; Bruzzese T; Buffa G; Bonabello A Chemotherapy; 2000; 46(3):153-9. PubMed ID: 10765028 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of a new polyene SPK-843 against Candida spp, Cryptococcus neoformans and Aspergillus spp clinical isolates. Kantarcioglu AS; Yucel A; Vidotto V J Chemother; 2003 Jun; 15(3):296-8. PubMed ID: 12868560 [No Abstract] [Full Text] [Related]
16. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice. Gadebusch HH; Pansy F; Klepner C; Schwind R J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355 [TBL] [Abstract][Full Text] [Related]
17. Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans. Barchiesi F; Schimizzi AM; Caselli F; Giannini D; Camiletti V; Fileni B; Giacometti A; Di Francesco LF; Scalise G J Antimicrob Chemother; 2001 Dec; 48(6):769-73. PubMed ID: 11733459 [TBL] [Abstract][Full Text] [Related]
18. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. Klepser ME; Wolfe EJ; Pfaller MA J Antimicrob Chemother; 1998 Mar; 41(3):397-401. PubMed ID: 9578168 [TBL] [Abstract][Full Text] [Related]